Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

HSA Approval

ELZONRIS CONCENTRATE FOR SOLUTION FOR INFUSION 1000 MCG/ML

Approval Number

SIN17059P

Drug Name

ELZONRIS CONCENTRATE FOR SOLUTION FOR INFUSION 1000 MCG/ML

Product Name

ELZONRIS CONCENTRATE FOR SOLUTION FOR INFUSION 1000 MCG/ML

Approval Date

August 5, 2024

Registrant

A. MENARINI SINGAPORE PTE. LTD.

Regulatory Information

Registrant

A. MENARINI SINGAPORE PTE. LTD.

Drug Type

Therapeutic

Forensic Classification

Prescription Only

Formulation Information

Dosage Form

INFUSION, SOLUTION CONCENTRATE

Route of Administration

INTRAVENOUS

Medical Information

ATC Code

L01XX67

Manufacturer Information

Pharmaceutical Manufacturer

A. MENARINI SINGAPORE PTE. LTD.

Manufacturers

Alcami Carolinas Corporation

Active Ingredients

Ingredient Name

TAGRAXOFUSP

Strength

1.0 MG/mL

Drug MonographTagraxofusp

Documents

Package Inserts

Elzonris Infusion PI.pdf

Approved: August 5, 2024

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy